BD MediButamirate Citrate
Cough suppressant
Brands & Prices (67)
📋 Indications & Uses Dosage & Administration⚠️ Contraindications⚡ Side Effects & Adverse Reactions🛡️ Warnings & Precautions🔬 Pharmacology & Mechanism
Brand Formulations & Prices
67 brands sorted by unit price
Bucod SR
Tkof SR
Askorel SR
Burat CR
Buratuss SR
Butakof
Butasiv
Cofof
Meera SR
Miratix SR
Sinakof
Tussibic
Butaret SR
Kofnix SR
Deconil SR
Mirakof SR
Bukof
Drycofix SR
Sinecod SR
Askorel
Bukof Kids
Buratuss
Butacit
Butafix
Butasiv
Kofnix
Mirakof
Miraten
Miratix
Butaret
Endkof
Tkof
Askorel
Bidicod
Bidkof
Biokof
Bucod
Bulex
Bupec
Buratuss
Butacit
Butacod
Butafix
Butakof
Butasiv
Butil
Cofof
Drycofix
Kofnix
Medulax
Meera
Miracit
Mirapex
Miraten
Miratix
Mita
Pintus
Supreno
Tamicod
Tamicol
Tussibic
Bukof-D
Butaret
Deconil
Mirakof
Bukof
Cofcut
📖 Official Clinical Monograph
DGDA Approved Prescribing GuidelinesAskorel is used to relieve dry (non-productive) cough. Dry cough may be caused by a recent viral infection. Askorel is also used for pre & post-operative cough, sedation in patients who will undergo surgical procedures and bronchoscopy. It can be used in the acute cough of any etiology, whooping cough and cough due to acute lower respiratory tract infections (tracheitis, laryngitis, bronchitis) etc.
Dosage & AdministrationUse in adult
:
Butamirate Citrate 50 mg tablet: 2-3 tablets daily.
Butamirate Citrate syrup: 15 ml 4 times daily.
Use in children & adolescents
:
Butamirate Citrate 50 mg tablet:
Adolescent over 12 years old: 1-2 tablets daily.
Butamirate Citrate syrup:
Children (3-6 yrs): 5 ml 3 times daily.
Children (6-12 yrs): 10 ml 3 times daily.
Adolescent: 15 ml 3 times daily.
Butamirate Citrate pediatric drops:
Children ( 2 months- 1 yrs): 0.50 ml 4 times daily.
Children (1-3 yrs): 0.75 ml 4 times daily.
Hypersensitivity to the active ingredient.
Tolerance of Askorel is good.Adverse reactions such as rash,nausea,diarrhoea and vertigo have been observed in a few rare cases,resolving after dose reduction or treatment withdrawal.
Askorel suppresses the cough reflex and therefore the concomitant use with expectorants should be avoided, since it may lead to mucus retention in the airways, which increases the risk of bronchospasm and respiratory infections. If the cough persists for more than 7 days (more than 3 days in children younger than12 years of age) doctor must be consulted.
Butamirate Citrate acts directly on the brain's cough center to suppress cough. Butamirate Citrate is safe and non-sedating which is neither chemically nor pharmacologically related to opium alkaloids. Butamirate Citrate is rapidly and completely absorbed after oral administration. Maximum concentration is reached within 9 hours with the sustained-release tablet. This is extremely protein-bound and plasma elimination half-life is about 13 hours. The active metabolites of Butamirate Citrate have also antitussive action.